Neko Health Bolsters Preventative Healthcare with $260 Million Funding
Stockholm-based startup Neko Health has secured $260 million in Series B funding, valuing the company at $1.8 billion post-money, TechCrunch exclusively reports.
The investment, led by Lightspeed Venture Partners, will fuel Neko's expansion into the US market, enhance its diagnostics, and establish additional clinics in response to surging demand. With an extended waitlist now exceeding 100,000 individuals, Neko has evaluated 10,000 patients through its clinics in Stockholm and London.
"There's an undeniable demand for a holistic approach to healthcare," said CEO and co-founder Hjalmar Nilsonne. "This funding enables us to contribute to the ecosystem in the US, where a significant portion of our waitlist resides."
Neko's innovative clinics provide hour-long examinations, generating "millions of health data points" through proprietary hardware and software. These screenings assess skin cancer risk, metabolic syndrome, stroke, diabetes, and other health conditions, providing personalized recommendations and follow-ups.
"Neko's vertically integrated model differentiates us," added Nilsonne. "We design and manufacture our devices, develop our software, and operate our clinics, ensuring continuous improvement and value for our customers."
Founded in 2018 by Nilsonne and Spotify co-founder Daniel Ek, Neko has experienced rapid growth amid shifting healthcare trends. The company aims to leverage technological advancements in medicine to empower individuals with insights into their health and prevent potential issues.
Neko's focus on preventative diagnostics differentiates it from competitors like Zoi in France and Aware in Germany, as well as public health services like the UK's NHS Health Check. The company's commitment to affordable and high-quality screenings aims to address core challenges in healthcare and improve health outcomes.
"This funding will enable Neko to double down on product development and innovation," said Nilsonne. "We envision a future where yearly updates introduce expanded parameters and tiered service options, unlocking the potential for personalized and comprehensive preventative healthcare."